For the Inventor, By the Inventor

Enter assignee name

North York, Canada

Connaught Laboratories Limited

USPTO Granted Patents = 145

% Expired Patents = 2.1

CIPO Patents = 1

EPO Patents = 2

Trademarks = 4

Forward Citations = 2,218

Loading Chart...

Loading Chart...

116 inventors (with patents filed for the assignee):

Michel Henri Klein (96 out of 164 patents)

Pele Chong (44 out of 63 patents)

Sheena M Loosmore (41 out of 68 patents)

4. Yan-Ping Yang (27 out of 43 patents)

5. Raymond P Oomen (18 out of 50 patents)

6. Mary E Ewasyshyn (13 out of 27 patents)

7. Benjamin Rovinski (12 out of 31 patents)

8. Robert S Becker (12 out of 15 patents)

9. Gavin Ross Zealey (12 out of 13 patents)

10. Robin E Harkness (11 out of 22 patents)

11. Anthony Bernard Schryvers (11 out of 30 patents)

12. Andrew D Murdin (10 out of 44 patents)

13. Run-Pan Du (10 out of 19 patents)

14. Stephen A Cockle (10 out of 11 patents)

15. Charles D Sia (10 out of 10 patents)

Core Competencies:

Immunological Compositions

Vaccine Development

Transferrin Receptor

Chimeric Proteins

Viral Envelope Proteins

Synthetic Peptides

Immune Response

Respiratory Syncytial Virus

Pertussis Toxin

Nucleic Acids

Antigen Detection

Biodegradable Microparticles

145 patents: Sort by Forward Citations

1. 7235243 - Immunological combination compositions and methods (2007-06-26),

2. 7118749 - Transferrin receptor genes (2006-10-10),

3. 6984385 - Immunological combination compositions and methods (2006-01-10),

4. 6538118 - Expression of lipoproteins (2003-03-25),

5. 6444211 - Purification of a pertussis outer membrane protein (2002-09-03),

6. 6403102 - Chlamydia antigens and corresponding DNA fragments and uses thereof (2002-06-11),

7. 6403101 - Chlamydia antigens and corresponding DNA fragments and uses thereof (2002-06-11),

8. 6379675 - Immunological combination compositions and methods (2002-04-30),

9. 6306637 - Production of virus and purification of viral envelope proteins for vaccine use (2001-10-23),

10. 6291157 - Antigenically-marked non-infectious retrovirus-like particles (2001-09-18),

11. 6262016 - Transferrin receptor genes (2001-07-17),

12. 6251405 - Immunological combination compositions and methods (2001-06-26),

13. 6245549 - Production of virus and purification of viral envelope proteins for vaccine use (2001-06-12),

14. 6235523 - Vectors for DNA immunization against cervical cancer (2001-05-22),

15. 6228423 - Biodegradable targetable microparticle delivery system (2001-05-08),

Connaught Laboratories Limited is a pharmaceutical company specializing in the research, development, and production of vaccines. With a strong emphasis on innovation and quality, Connaught Laboratories is dedicated to improving global health and preventing infectious diseases. They have an extensive portfolio of vaccines for various diseases, including influenza, hepatitis, and polio. Committed to making vaccines accessible worldwide, Connaught Laboratories collaborates with healthcare organizations and government agencies to ensure the provision of life-saving vaccines to communities in need. Visit their website to learn more about their products, research projects, and global initiatives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

145 Patents

#1 in North York

#83 in Canada

#5,604 in the World

North York, Canada

Connaught Laboratories Limited

Forward Citations = 2,218

116 inventors:

Michel Henri Klein (96 out of 164 patents)

Pele Chong (44 out of 63 patents)

Sheena M Loosmore (41 out of 68 patents)

4. Yan-Ping Yang (27 out of 43 patents)

5. Raymond P Oomen (18 out of 50 patents)

Please report any incorrect information to [email protected]

Loading…